Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.

Due to the poor prognosis of advanced metastatic melanoma, it is crucial to find early biomarkers that help identify which melanomas will metastasize. By comparing the gene expression data from primary and cutaneous melanoma samples from The Cancer Genome Atlas (TCGA), we identified GPC6 among a set...

Full description

Bibliographic Details
Published in:	PLoS ONE
Main Authors:	Yuanyuan Li, Melissa Li, Igor Shats, Juno M Krahn, Gordon P Flake, David M Umbach, Xiaoling Li, Leping Li
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2019-01-01
Online Access:	https://doi.org/10.1371/journal.pone.0218067

Similar Items

Metastatic Cutaneous Melanoma of the Gallbladder
by: Dhruvan Patel, et al.
Published: (2017-01-01)

Can glypican-3 be a disease-specific biomarker?
by: Chaolei Chen, et al.
Published: (2017-05-01)

Prognostic impact of autophagy biomarkers for cutaneous melanoma.
by: Diana Yao Li Tang, et al.
Published: (2016-11-01)

The Glypican 3-Hosted Murine Mir717 Gene: Sequence Conservation, Seed Region Polymorphisms and Putative Targets
by: Tanja Kunej, Dasa Jevsinek Skok, Simon Horvat, Peter Dovc, Zhihua Jiang
Published: (2010-01-01)

The Identification of Prognostic and Metastatic Alternative Splicing in Skin Cutaneous Melanoma
by: Runzhi Huang, et al.
Published: (2022-01-01)

A novel prognostic model for patients with metastatic cutaneous melanoma
by: T. Hackmann, et al.
Published: (2026-01-01)

Diffuse cutaneous melanosis: rare complication of metastatic melanoma
by: Ana Cristina Vervloet do Amaral, et al.
Published: (2017-01-01)

Clinical Utility of Plasma Glypican-3 and Osteopontin as Biomarkers of Hepatocellular Carcinoma
Published: (2014-03-01)

A metastatic malign melanoma case with diffuse cutaneous melanosis
by: Zeynep Oruç, et al.
Published: (2016-08-01)

The features of leptin and its receptor expression in metastatic cutaneous melanoma
by: A. A. Lushnikova, et al.
Published: (2015-06-01)

From the Cochrane Library: Systemic Treatments for Metastatic Cutaneous Melanoma
by: Austin Hamp, et al.
Published: (2021-09-01)

Novel Treatments for Metastatic Cutaneous Melanoma and the Management of Emergent Toxicities
by: Charlotte Lemech, et al.
Published: (2012-01-01)

Performance of Serum Glypican 3 in Diagnosis of Hepatocellular Carcinoma: A meta-analysis
by: Dahai Xu, et al.
Published: (2019-01-01)

Glypican-1-targeted antibody–drug conjugate inhibits the growth of glypican-1-positive glioblastoma
by: Shun Uchida, et al.
Published: (2024-04-01)

PTPRC functions as a prognosis biomarker in the tumor microenvironment of cutaneous melanoma
by: Xuemei Li, et al.
Published: (2023-11-01)

Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.
by: Ching-Ni Jenny Njauw, et al.
Published: (2012-01-01)

A novel patient-derived cutaneous melanoma cell line reveals key features of metastatic melanoma
by: Ana Tomás, et al.
Published: (2025-07-01)

A Case of Gastric Metastatic Melanoma 15 Years after the Initial Diagnosis of Cutaneous Melanoma
by: Sohail Farshad, et al.
Published: (2018-01-01)

The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma
by: Xiaobei Zhao, et al.
Published: (2019-01-01)

A Synopsis of Serum Biomarkers in Cutaneous Melanoma Patients
by: Pierre Vereecken, et al.
Published: (2012-01-01)

Cutaneous malignant melanoma and targeted therapy based on the biomarkers
by: Jayabal Pandiaraja
Published: (2019-01-01)

MAY GLYPICAN-3 BE A NOVEL BIOMARKER AND POTENTIAL THERAPEUTIC TARGET IN HEPATOCELLULAR CANCER?
by: Irina I. Ivanova
Published: (2018-03-01)

Neuroendocrine tumors show altered expression of chondroitin sulfate, glypican 1, glypican 5 and syndecan 2 depending on their differentiation grade
by: Olivia eGarcía-Suárez, et al.
Published: (2014-02-01)

CDCA3 is a prognostic biomarker for cutaneous melanoma and is connected with immune infiltration
by: Tianhao Li, et al.
Published: (2023-01-01)

Ubiquitination-related biomarkers in metastatic melanoma patients and their roles in tumor microenvironment
by: Li Zhang, et al.
Published: (2023-05-01)

Integrated Meta-Analysis Identifies Keratin Family Genes and Associated Genes as Key Biomarkers and Therapeutic Targets in Metastatic Cutaneous Melanoma
by: Sumaila Abubakari, et al.
Published: (2025-07-01)

Differences in the pathological, transcriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomas
by: Jin Xu, et al.
Published: (2024-11-01)

New Prognostic Biomarkers and Drug Targets for Skin Cutaneous Melanoma via Comprehensive Bioinformatic Analysis and Validation
by: Sitong Zhou, et al.
Published: (2021-10-01)

Association Between Blood Transfusion and Survival Outcomes in Metastatic Cutaneous Melanoma Treated with Nivolumab
by: Coskun A, et al.
Published: (2026-06-01)

Intra-arterial perfusion-based therapies for regionally metastatic cutaneous and uveal melanoma
by: Kristy K Broman, et al.
Published: (2019-11-01)

Primary and Metastatic Cutaneous Melanomas Discriminately Enrich Several Ligand-Receptor Interactions
by: Michael J. Diaz, et al.
Published: (2023-01-01)

RAC1 Activation as a Potential Therapeutic Option in Metastatic Cutaneous Melanoma
by: Paula Colón-Bolea, et al.
Published: (2021-10-01)

Cutaneous Melanoma in a Rabbit With Multiple Metastatic Lesions: A Case Report
by: Amir Rostami, et al.
Published: (2026-01-01)

Pilot study of topical imiquimod combined with pembrolizumab for unresectable cutaneous metastatic melanoma
by: Joseph B. Parker, et al.
Published: (2026-06-01)

Cutaneous metastatic melanoma in a Siberian tiger (Panthera tigris altaica) - case report
by: C. Eckstein, et al.
Published: (2020-07-01)

A Statistical Approach to the Diagnosis and Prediction of HCC Using CK19 and Glypican 3 Biomarkers
by: Călin Burciu, et al.
Published: (2023-03-01)

Drug targets and predictive biomarkers in the management of metastatic melanoma
by: Thumar J, et al.
Published: (2012-09-01)

Methylated circulating tumor DNA as a biomarker in cutaneous melanoma
by: Russell J Diefenbach, et al.
Published: (2020-09-01)

Pan-cancer analysis and the oncogenic role of Glypican 1 in hepatocellular carcinoma
by: Li Cao, et al.
Published: (2024-07-01)

Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma
by: Nicolas Jacquelot, et al.
Published: (2017-08-01)